Nurix Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -16.9% | -42.7% | +66.9% | +29.8% | +99.3% | -29.1% | +54.0% | |
| – | +11.1% | +47.7% | -90.9% | +77.7% | +1,650.1% | +17.2% | -91.5% | |
| – | – | – | +66.9% | +29.8% | -390.4% | – | – | |
| – | +11.1% | +47.7% | +75.1% | +58.5% | +2.5% | +17.2% | +39.0% | |
| – | +24.8% | +95.9% | +91.3% | +21.8% | +12.9% | +7.1% | +14.8% | |
| – | +24.8% | +894.5% | +78.3% | +50.7% | -80.7% | +7.1% | +663.5% | |
| – | – | – | – | – | – | – | – | |
| – | -5.1% | +336.3% | +103.9% | +107.3% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -52.9% | -8,692.1% | – | -11,027.5% | – | -98.0% | +181.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.